Michael Robert Martin - Sep 14, 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Chief Business Officer
Signature
/s/ Michael Robert Martin
Stock symbol
AUPH
Transactions as of
Sep 14, 2021
Transactions value $
-$725,020
Form type
4
Date filed
9/16/2021, 05:01 PM
Previous filing
Sep 14, 2021
Next filing
Sep 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Options Exercise $233K +44K +24.88% $5.30 221K Sep 14, 2021 Direct F1
transaction AUPH Common Shares Sale -$304K -14K -6.34% $21.73 207K Sep 14, 2021 Direct F2, F3
transaction AUPH Common Shares Sale -$654K -30K -14.5% $21.80 177K Sep 14, 2021 Direct F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Option Grant (right to buy) Options Exercise $0 -44K -55% $0.00 36K Sep 14, 2021 Common Stock 44K $5.30 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in connection with a divorce agreement.
F3 The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.71 to $21.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F5 The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.75 to $21.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 The shares subject to the option vest in thirty-six equal monthly installments from the grant date.